While the European Union does not currently have a dedicated framework for modern nicotine products, several jurisdictions have already developed regulatory approaches that provide useful reference points for policymakers.
These examples demonstrate that nicotine products can be regulated through frameworks that balance consumer protection, product oversight, youth safeguards, and adult access without relying solely on traditional tobacco legislation.
Sweden: A Global Benchmark for Harm Reduction
Sweden is frequently cited as one of the most significant case studies in modern nicotine regulation.
Nicotine pouches are regulated as consumer products rather than tobacco products, while age restrictions, product-safety requirements, and market controls remain in place. This approach reflects a broader Swedish policy philosophy that recognises differences between combustible and non-combustible nicotine products.
Sweden’s long history with snus and other smoke-free nicotine products has coincided with some of the lowest smoking rates in Europe. As a result, Sweden is often referenced in international discussions about risk-proportionate regulation and tobacco harm reduction.
For European policymakers considering future nicotine frameworks, Sweden provides an example of how differentiated regulation can coexist with strong public health oversight.
United Kingdom: Proportionate and Evidence-Led Regulation
The United Kingdom has adopted a regulatory approach that increasingly emphasises proportionality and evidence-based policymaking.
At present, nicotine pouches are regulated under General Product Safety Regulations. However, the recently adopted Tobacco and Vapes Act will introduce additional measures including age restrictions, marketing controls, product requirements, and broader regulatory oversight.
Importantly, UK policymakers have consistently acknowledged the potential role that lower-risk nicotine products may play within broader smoking reduction strategies while maintaining strong protections for young people.
Rather than treating all nicotine products identically, the UK model increasingly focuses on balancing public health objectives, consumer protection, and regulatory certainty.
Switzerland: Open but Structured
Switzerland represents another example of a relatively open but highly structured framework.
Nicotine pouches are regulated as consumer products and are subject to formal oversight mechanisms, including licensing requirements and nicotine-content controls.
This approach seeks to maintain product availability for adults while ensuring that quality standards, consumer information requirements, and regulatory safeguards remain in place.
Switzerland is frequently viewed as one of Europe’s more adult-access-oriented regulatory environments, while still retaining a strong emphasis on product oversight and consumer protection.
Czech Republic: Product Safety and Regulatory Clarity
The Czech Republic has developed one of Europe’s clearest regulatory frameworks for nicotine pouches.
Products are regulated through legislation that requires ingredient disclosure, product reporting, and supporting health-impact documentation. The emphasis is on product safety, transparency, and regulatory accountability rather than outright restriction.
This approach is often viewed as a structured middle ground between highly restrictive frameworks and more open market environments.
For policymakers, the Czech model illustrates how regulatory certainty can be achieved without necessarily resorting to prohibition.
United States: Science-Driven but Highly Demanding
The United States offers a different perspective.
Under the authority of the Food and Drug Administration (FDA), nicotine pouches are regulated as tobacco products, including products containing synthetic nicotine. Manufacturers must submit extensive scientific evidence through the Premarket Tobacco Product Application (PMTA) process before products can receive marketing authorization.
In 2025, the FDA authorised multiple ZYN nicotine pouch products following scientific review, establishing an important precedent for evidence-based regulatory access.
The U.S. framework is among the most scientifically demanding in the world. While it is generally considered less open than Sweden or the United Kingdom, it demonstrates how rigorous scientific review can be incorporated into nicotine regulation without automatically resulting in prohibition.
A Common Theme
Although these jurisdictions differ significantly in their regulatory philosophies, they share an important characteristic: each has developed regulatory mechanisms specifically designed to address modern nicotine products rather than relying entirely on frameworks originally created for combustible tobacco.
This raises an important question for Europe.
As nicotine products continue to diversify, should future regulation continue to rely primarily on adaptations of tobacco legislation, or is the time approaching for a dedicated framework capable of addressing the realities of contemporary nicotine markets?
